Daily Newsletter

13 February 2024

Daily Newsletter

13 February 2024

Canary Medical completes cardiac sensor device trial

The first-in-human trial of the Canary’s cardiac auscultation sensor device has been carried out in Paraguay.

Archana Rani February 13 2024

Canary Medical has completed the first-in-human clinical trial of its Cardiac Auscultation monitoring sensor device.

The new implantable sensor is aimed at enhancing the management of congestive heart failure symptoms.

Conducted in Paraguay, the limited feasibility trial has demonstrated the device's potential in providing daily objective cardiac parameter measurements.

This enables clinicians and patients to better manage their symptoms with medication management tools that are currently available.

The limited feasibility trial focused on evaluating the sensitivity, specificity, and design specifications of the microphone system of the device.

Two patients were part of this trial, which confirmed the sensor's ability to detect mitral regurgitation sound signals, distinguishing them from normal acoustic heart signals.

Canary Medical founding member and CEO Bill Hunter said: “Today, Canary Medical announced the first step in expanding our sensor technology applications outside of orthopedics. The Cardiac Auscultation monitor is just one of the exciting new products that will drive the future growth of our company.

“Congratulations to our world-class research and development team and thank you to the individuals who were the first to receive this new technology. While these are early results, we believe that the future is bright for patients who will benefit from Canary’s expanded sensor portfolio in the years to come.”

In the US, heart failure market is expected to reach $70bn annually by 2030.

In 2022, Canary Medical launched Canary Quantiles Recovery Curves, its first orthopaedic analytic module.

The new Canary Quantiles Recovery Curves software is designed to provide additional aggregate population data to healthcare professionals while managing a patient’s total knee arthroplasty after surgery.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close